Ionic Liquids and Deep Eutectic Solvents for Application in Pharmaceutics
Dear Colleagues, In recent years, functional coating technology has attracted increased attention due to its effective potential for improved engineered materials. Growing demand for new materials with synergistic properties pushed research toward a new field to obtain innovative and smart coating...
Shranjeno v:
| Drugi avtorji: | , |
|---|---|
| Format: | Book Chapter |
| Izdano: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Teme: | |
| Online dostop: | Get Fullteks DOAB: description of the publication |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
| LEADER | 03771naaaa2200817uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_76729 | ||
| 005 | 20220111 | ||
| 020 | |a books978-3-0365-0057-7 | ||
| 020 | |a 9783036500560 | ||
| 020 | |a 9783036500577 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-0057-7 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 100 | 1 | |a Branco, Luis Cobra |4 edt | |
| 700 | 1 | |a Santos, Miguel |4 edt | |
| 700 | 1 | |a Branco, Luis Cobra |4 oth | |
| 700 | 1 | |a Santos, Miguel |4 oth | |
| 245 | 1 | 0 | |a Ionic Liquids and Deep Eutectic Solvents for Application in Pharmaceutics |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (154 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Dear Colleagues, In recent years, functional coating technology has attracted increased attention due to its effective potential for improved engineered materials. Growing demand for new materials with synergistic properties pushed research toward a new field to obtain innovative and smart coatings with functional capabilities that greatly differ from the conventional ones. In such a context, the expression of "functional coatings" has acquired specific relevance. This Special Issue will assess cutting-edge developments in this research area for the improvement and growth of actual performance, industrial scale-up, and marketability of functional coatings. This Special Issue is useful for researchers who are approaching this application context to improve their knowledge, with the aim of providing valuable scientific support for new research paths concerning functional surface engineering design and tailoring. Prof. Luigi Calabrese, Prof. Edoardo Proverbio Guest Editors | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 653 | |a ionic liquids | ||
| 653 | |a transdermal | ||
| 653 | |a synergy | ||
| 653 | |a permeation enhancer | ||
| 653 | |a chemical | ||
| 653 | |a physical | ||
| 653 | |a Transdermal drug delivery systems | ||
| 653 | |a ionic liquid | ||
| 653 | |a lipophilic salt | ||
| 653 | |a drug delivery | ||
| 653 | |a drug absorption | ||
| 653 | |a poorly water-soluble drug | ||
| 653 | |a lumefantrine | ||
| 653 | |a lipid-based formulation | ||
| 653 | |a SEDDS | ||
| 653 | |a lipid formulation classification system | ||
| 653 | |a active pharmaceutical ingredients-ionic liquids and organic salts (API-OSILs) | ||
| 653 | |a penicillin G and amoxicillin hydrolysate derivatives | ||
| 653 | |a sensitive bacteria | ||
| 653 | |a resistant bacteria | ||
| 653 | |a alendronic acid | ||
| 653 | |a Active Pharmaceutical Ingredients | ||
| 653 | |a API-OSILs | ||
| 653 | |a anticancer drugs | ||
| 653 | |a deep eutectic mixtures | ||
| 653 | |a ketoprofen | ||
| 653 | |a non-steroidal anti-inflammatory drugs (NSAIDs) | ||
| 653 | |a local anesthetics | ||
| 653 | |a procaine | ||
| 653 | |a benzocaine | ||
| 653 | |a tetracaine | ||
| 653 | |a anticrystal engineering | ||
| 653 | |a mechanochemistry | ||
| 653 | |a biocompatible | ||
| 653 | |a transdermal drug delivery system | ||
| 653 | |a microemulsion | ||
| 653 | |a active pharmaceutical ingredients as organic salts and ionic liquids (API-OSILs) | ||
| 653 | |a antibiotics | ||
| 653 | |a ciprofloxacin | ||
| 653 | |a fluoroquinolones | ||
| 653 | |a norfloxacin | ||
| 653 | |a polymorphism | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4178 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76729 |7 0 |z DOAB: description of the publication |